Binaltorphimine
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C41H45N3O6 |
Molar mass | 675.826 g·mol−1 |
3D model (JSmol) | |
| |
InChI
|
Binaltorphimine (BNI) is a selective antagonist of the κ-opioid receptor (KOR).[1] BNI and norbinaltorphimine (nor-BNI) were the first highly selective KOR antagonists to be discovered.[1]
See also[]
References[]
- ^ a b Portoghese PS, Lipkowski AW, Takemori AE (March 1987). "Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists". Life Sci. 40 (13): 1287–92. doi:10.1016/0024-3205(87)90585-6. PMID 2882399.
Categories:
- Drugs not assigned an ATC code
- Morphinans
- Phenols
- Tertiary alcohols
- Kappa-opioid receptor antagonists
- Nervous system drug stubs